J0179 Inj, brolucizumab-dbll, 1 mg

Injection, brolucizumab-dbll, 1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 12 units per day (practitioner), rationale: Anatomic Consideration